(0.27%) 5 145.50 points
(0.17%) 38 505 points
(0.41%) 17 920 points
(-0.64%) $83.31
(2.18%) $1.965
(-0.14%) $2 344.00
(-0.17%) $27.49
(2.85%) $948.35
(-0.05%) $0.934
(-0.09%) $11.01
(-0.28%) $0.798
(1.85%) $93.57
0.00% $ 90.00
Live Chart Being Loaded With Signals
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar...
Stats | |
---|---|
Tagesvolumen | 309.00 |
Durchschnittsvolumen | 23.00 |
Marktkapitalisierung | 0.00 |
Last Dividend | $0.145 ( 2017-03-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | 3 000.00 |
ATR14 | $0 (0.00%) |
ALK-Abelló A/S Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
ALK-Abelló A/S Finanzdaten
Annual | 2021 |
Umsatz: | $3.92B |
Bruttogewinn: | $2.40B (61.18 %) |
EPS: | $0.200 |
FY | 2021 |
Umsatz: | $3.92B |
Bruttogewinn: | $2.40B (61.18 %) |
EPS: | $0.200 |
FY | 2020 |
Umsatz: | $3.49B |
Bruttogewinn: | $2.03B (58.09 %) |
EPS: | $0.0229 |
FY | 2019 |
Umsatz: | $3.27B |
Bruttogewinn: | $1.89B (57.79 %) |
EPS: | $-0.0459 |
Financial Reports:
No articles found.
ALK-Abelló A/S Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.152 | 2015-03-25 |
Last Dividend | $0.145 | 2017-03-15 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $0.448 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.21 | -- |
Div. Sustainability Score | 8.33 | |
Div.Growth Potential Score | 2.89 | |
Div. Directional Score | 5.61 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
YKLTF | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
MRPLY | Ex Dividend Junior | 2023-07-13 | Annually | 0 | 0.00% | |
CNPWM | Ex Dividend Knight | 2023-07-07 | Quarterly | 0 | 0.00% | |
STWRY | Ex Dividend Junior | 2023-05-19 | Annually | 0 | 0.00% | |
HLFN | Ex Dividend Knight | 2023-07-27 | Quarterly | 0 | 0.00% | |
ASHTY | Ex Dividend Knight | 2023-08-10 | Semi-Annually | 0 | 0.00% | |
OPHLF | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
DITTF | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
TREAY | No Dividend Player | 2023-06-26 | Annually | 0 | 0.00% | |
JAIRF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0559 | 1.500 | 8.88 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0376 | 1.200 | 8.75 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0660 | 1.500 | -0.377 | -0.566 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.735 | 0.800 | 6.32 | 5.06 | [1 - 3] |
quickRatioTTM | 0.140 | 0.800 | -3.88 | -3.11 | [0.8 - 2.5] |
cashRatioTTM | 0.140 | 1.500 | -0.333 | -0.499 | [0.2 - 2] |
debtRatioTTM | 0.122 | -1.500 | 7.97 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 13.13 | 1.000 | 6.25 | 6.25 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.426 | 2.00 | 9.86 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.186 | 2.00 | 9.91 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.204 | -1.500 | 9.18 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.612 | 1.000 | 3.14 | 3.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0771 | 1.000 | -0.458 | -0.458 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.659 | 1.000 | 7.45 | 7.45 | [0.2 - 2] |
assetTurnoverTTM | 0.672 | 0.800 | 8.86 | 7.08 | [0.5 - 2] |
Total Score | 8.33 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 3 141.11 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0660 | 2.50 | -0.243 | -0.566 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.186 | 2.00 | 9.94 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.426 | 2.00 | 9.86 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -22.59 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.51 | 0 | [0.1 - 0.5] |
Total Score | 2.89 |
ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.